Cryptocurrency News

Remarkable Shift: Arthur Hayes Champions Longevity Revolution After Trump Pardon with Major Stem Cell Investment

Arthur Hayes discussing longevity investments in modern biotechnology laboratory setting

BitMEX co-founder Arthur Hayes makes a dramatic career pivot into longevity biotechnology following his presidential pardon, signaling a growing trend among crypto billionaires investing in life extension technologies.

Arthur Hayes Embraces Longevity Mission

Former BitMEX CEO Arthur Hayes has taken a board position and significant financial stake in an undisclosed stem cell company. This strategic move follows his March pardon from President Donald Trump, which cleared his conviction for Bank Secrecy Act violations. Hayes has been receiving treatments at the company’s clinics in Mexico and Bangkok for over a year.

Crypto Titans Pursue Longevity Solutions

Hayes joins several prominent cryptocurrency figures investing heavily in longevity research. Notably:

  • Vitalik Buterin donated $25 million in SHIB tokens to longevity research
  • Brian Armstrong co-founded genetic startup NewLimit with $130 million funding
  • Balaji Srinivasan established genomics company Counsyl for genetic testing

Regulatory Landscape Evolves

Hayes emphasized that more countries are relaxing regulations around stem cell therapies. Consequently, this creates new opportunities for investment and treatment accessibility. The company involved is currently undergoing rebranding while expanding its operations.

Continued Crypto Involvement

Despite his new focus on longevity, Hayes maintains active cryptocurrency investments through his family office Maelstrom. His fund supports digital asset treasury companies and launched a Bitcoin grant program offering $50,000-$250,000 annually for open-source development.

Industry Implications

The movement of crypto wealth into longevity research represents a significant shift in investment patterns. These developments suggest growing confidence in biotechnology’s potential to address aging-related challenges.

Frequently Asked Questions

What prompted Arthur Hayes’ interest in longevity research?
Hayes has been receiving stem cell treatments personally and stated he wants to “live as long as possible, as healthy as possible.”

Which other crypto leaders invest in longevity?
Vitalik Buterin, Brian Armstrong, and Balaji Srinivasan have all made significant investments in longevity and genetic research companies.

What legal background preceded this investment?
Hayes received a presidential pardon from Donald Trump in March, clearing his conviction related to Bank Secrecy Act violations at BitMEX.

How does Hayes balance crypto and longevity investments?
He maintains cryptocurrency investments through his Maelstrom fund while pursuing longevity ventures separately.

What treatments has Hayes received?
He has undergone stem cell therapies at clinics in Mexico and Bangkok for over a year.

Are stem cell treatments widely available?
Availability varies by country, with regulations gradually relaxing in multiple jurisdictions according to Hayes.

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

StockPII Footer
To Top